Cambricon
688256
Kweichow Moutai
600519
BYD Company Limited
002594
4
Hand Enterprise Solutions
300170
5
China Vanke Co.,Ltd.
000002
CN Stock MarketDetailed Quotes
603008 Xilinmen Furniture
- 16.61
- +0.25+1.53%
Market Closed Jan 24 15:00 CST
6.30BMarket Cap15.21P/E (TTM)
16.67High16.28Low50.96KlotVolume16.40Open16.36Pre Close84.21MTurnover1.34%Turnover Ratio14.67P/E (Static)378.99MShares21.6052wk High1.63P/B6.30BFloat Cap12.0252wk Low18.00Limit Up378.99MShs Float39.60Historical High14.72Limit Down2.38%Amplitude3.49Historical Low0.50Dividend TTM16.53Avg Price20.81KlotAsk3.01%Div YieldTTM100Lot Size28.44KlotBid
Xilinmen Furniture Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -1.53%5.98B | 4.02%3.96B | 20.02%1.76B | 10.71%8.68B | 5.71%6.07B | 5.53%3.8B | 4.47%1.47B | 0.86%7.84B | 13.85%5.74B | 16.05%3.61B |
| Operating revenue | -1.53%5.98B | 4.02%3.96B | 20.02%1.76B | 10.71%8.68B | 5.71%6.07B | 5.53%3.8B | 4.47%1.47B | 0.86%7.84B | 13.85%5.74B | 16.05%3.61B |
| Other operating revenue | ---- | 152.79%54.55M | ---- | 2.38%99.67M | ---- | 136.13%21.58M | ---- | -18.46%97.35M | ---- | -82.45%9.14M |
| Total operating cost | -1.06%5.59B | 5.01%3.71B | 16.96%1.68B | 7.96%8.12B | 6.95%5.64B | 5.59%3.53B | 5.86%1.44B | 6.27%7.52B | 13.92%5.28B | 15.72%3.34B |
| Operating cost | -3.22%3.86B | 4.75%2.58B | 18.13%1.17B | 7.49%5.7B | 4.48%3.99B | 3.39%2.46B | 7.44%992.11M | 0.27%5.3B | 10.37%3.82B | 11.16%2.38B |
| Operating tax surcharges | 5.80%39.96M | 9.84%24.84M | 110.98%12.84M | -7.58%54.9M | 7.79%37.77M | -4.47%22.61M | 18.87%6.08M | 12.01%59.4M | 9.46%35.04M | 17.59%23.67M |
| Operating expense | 4.27%1.21B | 3.37%768.95M | 15.26%337.45M | 14.93%1.76B | 17.75%1.16B | 15.59%743.89M | 4.56%292.77M | 28.18%1.53B | 28.20%982.71M | 30.09%643.58M |
| Administration expense | -0.31%320.79M | 3.05%222.09M | 18.11%106.58M | 3.77%422.66M | 10.19%321.79M | 14.43%215.5M | 0.31%90.24M | 29.64%407.28M | 44.67%292.02M | 48.75%188.32M |
| Financial expense | 164.57%28.68M | 1,102.78%17.42M | -69.15%6.17M | -69.03%11.67M | -60.48%10.84M | -93.93%1.45M | 6.79%20.01M | -27.26%37.7M | -28.74%27.43M | -7.98%23.85M |
| -Interest expense (Financial expense) | -21.57%59.88M | -36.13%37.56M | -40.53%16.68M | -21.94%70.23M | 24.12%76.35M | 27.99%58.81M | 19.43%28.04M | 36.33%89.96M | 14.31%61.51M | 34.66%45.95M |
| -Interest Income (Financial expense) | 43.12%-24.43M | 48.19%-15.75M | 43.82%-8.56M | -0.04%-29.98M | -68.41%-42.95M | -53.87%-30.4M | -82.30%-15.25M | 4.36%-29.97M | 1.30%-25.5M | -24.64%-19.76M |
| Research and development | 0.34%125.34M | 12.37%90.11M | 28.12%44.75M | -6.08%179.85M | 4.47%124.92M | 2.46%80.19M | -11.44%34.93M | 4.52%191.49M | -9.23%119.57M | 3.36%78.26M |
| Credit Impairment Loss | -119.26%-645.59K | 104.76%471.46K | -101.22%-285.13K | -199.40%-55.27M | 155.18%3.35M | -21.22%-9.9M | 366.25%23.39M | 69.15%-18.46M | 40.08%-6.07M | -41.35%-8.17M |
| Asset Impairment Loss | 122.58%765.71K | -66.82%125.68K | -91.14%33.57K | -430.07%-2.21M | -12.42%344.01K | -78.14%378.79K | -94.25%378.79K | -88.31%669.21K | -76.57%392.8K | -55.70%1.73M |
| Other net revenue | -10.63%50.76M | 440.57%33.76M | -87.48%4.57M | -87.69%3.15M | 40.91%56.8M | -68.46%6.25M | 72.51%36.51M | -6.07%25.56M | -39.04%40.31M | -64.66%19.8M |
| Fair value change income | -1,309.61%-7.46M | -338.36%-7.99M | -206.08%-9.63M | 94.61%-1.2M | 105.94%616.34K | 150.54%3.35M | --9.08M | -1,764.53%-22.36M | -154.44%-10.38M | -134.79%-6.63M |
| Invest income | 182.89%11.91M | 488.96%8.73M | 31.44%880.24K | 116.14%13.95M | 188.28%4.21M | 31.27%1.48M | 247.80%669.71K | -84.94%6.45M | -92.65%1.46M | -94.19%1.13M |
| -Including: Investment income associates | 353.89%8.33M | 14,843.33%8.31M | -126.93%-133.27K | 811.60%3.25M | 1,782.21%1.83M | -332.44%-56.35K | 340.22%494.93K | 165.25%356.58K | 111.01%97.49K | 100.93%24.24K |
| Asset deal income | 1,202.50%390.74K | 524.86%150.58K | ---- | -9,067.47%-1.45M | -107.98%-35.44K | -107.98%-35.44K | -1,199.60%-439.81K | -234.08%-15.87K | 2,791.76%444.37K | 2,767.85%444.37K |
| Other revenue | -5.20%45.8M | 194.16%32.27M | 295.54%13.57M | -16.77%49.34M | -11.29%48.31M | -64.94%10.97M | -65.59%3.43M | 59.63%59.28M | 52.85%54.46M | 61.54%31.29M |
| Operating profit | -8.14%441.95M | 1.19%286.3M | 26.85%85.98M | 64.33%557.75M | -4.44%481.09M | -0.40%282.93M | -1.96%67.78M | -52.75%339.4M | 5.78%503.44M | 3.08%284.07M |
| Add:Non operating Income | -23.84%3.6M | 56.19%2.51M | -63.80%704.73K | -34.09%3.92M | 74.63%4.72M | 166.88%1.61M | 842.08%1.95M | 245.60%5.95M | 70.75%2.71M | -17.71%603.26K |
| Less:Non operating expense | 1.64%16.23M | 35.90%12.79M | 70.12%3.87M | -72.88%6.26M | 17.68%15.97M | 60.61%9.41M | -41.76%2.28M | 81.14%23.09M | -12.29%13.57M | -32.95%5.86M |
| Total profit | -8.63%429.31M | 0.32%276.02M | 22.77%82.81M | 72.35%555.41M | -4.61%469.85M | -1.32%275.13M | 3.08%67.45M | -54.43%322.26M | 6.61%492.57M | 4.20%278.81M |
| Less:Income tax cost | -29.67%49.92M | -18.77%40.14M | 52.47%7.33M | 115.10%107.64M | -12.87%70.97M | 10.71%49.42M | 5.21%4.81M | -50.90%50.04M | 47.13%81.46M | 78.47%44.64M |
| Net profit | -4.88%379.4M | 4.51%235.88M | 20.49%75.47M | 64.49%447.77M | -2.98%398.87M | -3.61%225.71M | 2.92%62.64M | -55.03%272.22M | 1.10%411.11M | -3.46%234.17M |
| Net profit from continuing operation | -4.88%379.4M | 4.51%235.88M | 20.49%75.47M | 64.49%447.77M | -2.98%398.87M | -3.61%225.71M | 2.92%62.64M | -55.03%272.22M | 1.10%411.11M | -3.46%234.17M |
| Less:Minority Profit | -50.40%4.27M | -36.11%2.2M | 38.15%1.4M | -45.49%18.9M | -61.16%8.6M | -76.29%3.45M | -85.45%1.01M | -25.56%34.67M | -32.71%22.14M | -41.67%14.55M |
| Net profit of parent company owners | -3.88%375.13M | 5.14%233.68M | 20.20%74.08M | 80.54%428.87M | 0.33%390.27M | 1.20%222.26M | 14.30%61.63M | -57.49%237.55M | 4.07%388.98M | 0.92%219.62M |
| Earning per share | ||||||||||
| Basic earning per share | -1.98%0.99 | 10.53%0.63 | 18.75%0.19 | 79.03%1.11 | 1.00%1.01 | 0.00%0.57 | 14.29%0.16 | -57.24%0.62 | 4.17%1 | 1.79%0.57 |
| Diluted earning per share | -1.98%0.99 | 10.53%0.63 | 18.75%0.19 | 79.03%1.11 | 1.00%1.01 | 0.00%0.57 | 14.29%0.16 | -57.24%0.62 | 4.17%1 | 1.79%0.57 |
| Other composite income | 2.06%-7.08M | -230.93%-8.46M | -387.57%-8M | -19.48%4.89M | -10.93%-7.23M | 61.56%-2.56M | 147.04%2.78M | 210.51%6.07M | 49.87%-6.51M | 2.00%-6.65M |
| Other composite income of parent company owners | 2.06%-7.08M | -230.93%-8.46M | -387.57%-8M | -19.48%4.89M | -10.93%-7.23M | 61.56%-2.56M | 147.04%2.78M | 210.51%6.07M | 49.87%-6.51M | 2.00%-6.65M |
| Total composite income | -4.93%372.32M | 1.91%227.42M | 3.14%67.47M | 62.66%452.66M | -3.20%391.65M | -1.92%223.15M | 19.06%65.42M | -53.61%278.29M | 2.78%404.6M | -3.50%227.52M |
| Total composite income of parent company owners | -3.91%368.05M | 2.51%225.21M | 2.59%66.08M | 78.05%433.76M | 0.15%383.05M | 3.16%219.7M | 34.18%64.41M | -55.97%243.62M | 6.01%382.46M | 1.02%212.97M |
| Total composite income of minority owners | -50.40%4.27M | -36.11%2.2M | 38.15%1.4M | -45.49%18.9M | -61.16%8.6M | -76.29%3.45M | -85.45%1.01M | -25.56%34.67M | -32.71%22.14M | -41.67%14.55M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.